CNR2: Cannabinoid receptor 2
Heterotrimeric G protein-coupled receptor for endocannabinoid 2-arachidonoylglycerol mediating inhibition of adenylate cyclase.
- Drugs that act on it: 8
- Approved: 0
- In phases 1 to 3: 8
- Sponsors: 5
Who is on it, and how far along
Every drug ChEMBL records acting on CNR2, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Arena Pharmaceuticals113%
- Eli Lilly113%
- GSK113%
- Novartis Pharmaceuticals113%
- Shionogi113%
| GW842166X | Phase 2 | GSK | Small molecule | Agonist | 0 |
| LY2828360 | Phase 2 | Eli Lilly | Small molecule | Agonist | 0 |
| Nonabine | Phase 2 | — | Small molecule | Agonist | 0 |
| Olorinab | Phase 2 | Arena Pharmaceuticals | Small molecule | Agonist | 0 |
| PRS-211375 | Phase 2 | — | Small molecule | Agonist | 0 |
| S-777469 | Phase 2 | Shionogi | Small molecule | Agonist | 0 |
| Tedalinab | Phase 2 | — | Small molecule | Agonist | 0 |
| SAD448 | Phase 1 | Novartis Pharmaceuticals | Small molecule | Agonist | 0 |
- Neurodegenerative disease0.21
- Splenomegaly0.17
- Neoplasm0.11
- Pain0.10
- Atopic eczema0.10
- Breast cancer0.10
- Alopecia universalis congenita0.10
- Alzheimer disease0.10
- Alopecia - intellectual disability syndrome0.10
- Hypotrichosis simplex0.10
- Crohn disease0.10
- Breast carcinoma0.10
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL253, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P34972, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets